News | July 01, 2022
H Clinical adds commercial home health capabilities for pharma industry
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
H Clinical is the leader in decentralized clinical trial support and home visits in Latin America
NADMED technology is based on proprietary extraction and the individual measurement of NAD metabolites
A newly revealed mechanism by Weizmann Institute of Science of ketamine’s action on potassium channels in neurons may lead to improved therapies for depression
States were also strongly advised to strictly monitor epidemiological profile of admitted COVID patients
This includes USD 100 million to advance R&D of its neglected tropical disease program, focusing on novel drug candidates for four diseases.
Most recently, she served as chief human resources officer at Vyripharm Enterprises.
Becomes first Japanese logistics company to collaborate with EMBALL’ISO, which has a proven track record in vaccine transport
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Subscribe To Our Newsletter & Stay Updated
